Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12599566 | Titanium dioxide free white film coating composition, process for preparing the same and method of use thereof | 🖼🧊📄§ | 2026-04-14 | 2040-09-25 | 0 | 31 |
| 12600791 | Bispecific antibody, preparation method therefor and application thereof | 🖼🧊📄§ | 2026-04-14 | 2039-12-17 | 0 | 31 |
| 12599675 | Conjugate of immune-stimulating il-2 analog and preparation method thereof | 🖼🧊📄§ | 2026-04-14 | 2042-03-31 | 0 | 31 |
| 12601542 | Lyophilized reagents | 🖼🧊📄§ | 2026-04-14 | 2040-12-15 | 0 | 31 |
| 12600716 | Compounds for modulating activity of FXR and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-10-12 | 0 | 31 |
| 12600755 | Cobra 1/NELF-B as a booster for efficacy of CD8+ T cell-based therapy | 🖼🧊📄§ | 2026-04-14 | 2041-02-25 | 0 | 31 |
| 12599601 | Antifungal composition containing carbazole compound as active ingredient | 🖼🧊📄§ | 2026-04-14 | 2040-10-16 | 0 | 31 |
| 12599579 | Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids | 🖼🧊📄§ | 2026-04-14 | 2045-07-07 | 0 | 31 |
| 12599606 | Therapies with 3rd generation EGFR tyrosine kinase inhibitors | 🖼🧊📄§ | 2026-04-14 | 2043-08-22 | 0 | 31 |
| 12599603 | Methods of treatment | 🖼🧊📄§ | 2026-04-14 | 2040-09-03 | 0 | 31 |
| 12599617 | Methods of treating head and neck cancers with hemp extract | 🖼🧊📄§ | 2026-04-14 | 2042-10-26 | 0 | 31 |
| 12599571 | Method for preparing polydopamine nanomotor using urease, and use of same | 🖼🧊📄§ | 2026-04-14 | 2040-03-10 | 0 | 31 |
| 12599658 | Hepatitis B virus-specific T cell responses | 🖼🧊📄§ | 2026-04-14 | 2040-06-05 | 0 | 31 |
| 12600771 | Antibody for binding to interleukin 4 receptor | 🖼🧊📄§ | 2026-04-14 | 2043-11-15 | 0 | 31 |
| 12599602 | Methods for treating cholestasis | 🖼🧊📄§ | 2026-04-14 | 2044-01-25 | 0 | 31 |
| 12600729 | New-type benzazepine fused ring derivative | 🖼🧊📄§ | 2026-04-14 | 2042-03-04 | 0 | 31 |
| 12599635 | Compositions and treatments for ischemic injuries | 🖼🧊📄§ | 2026-04-14 | 2041-03-22 | 0 | 31 |
| 12600750 | Methods for inactivating and storing respiratory syncytial virus | 🖼🧊📄§ | 2026-04-14 | 2039-07-08 | 0 | 31 |
| 12600959 | PH20 polypeptide variants, formulations and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2045-03-05 | 0 | 31 |
| 12600778 | Rage antibodies, fragments and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-11-02 | 0 | 31 |
| 12600782 | Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-03-30 | 0 | 31 |
| 12600796 | Constructs for chimeric antigen receptors | 🖼🧊📄§ | 2026-04-14 | 2041-09-16 | 0 | 31 |
| 12600968 | Methods and compositions for reprogramming cells | 🖼🧊📄§ | 2026-04-14 | 2042-07-20 | 0 | 31 |
| 12600790 | Variant antibody that binds CD38 | 🖼🧊📄§ | 2026-04-14 | 2040-12-18 | 0 | 31 |
| 12600967 | SiRNA compound that inhibits complement factor B (CFB) | 🖼🧊📄§ | 2026-04-14 | 2042-07-18 | 0 | 31 |
| 12600760 | Chimeric antigen receptors targeting CD79B and CD19 | 🖼🧊📄§ | 2026-04-14 | 2039-12-13 | 0 | 31 |
| 12600751 | Modified S2 subunit of the coronavirus spike protein | 🖼🧊📄§ | 2026-04-14 | 2040-05-06 | 0 | 31 |
| 12599667 | Methods of preventing platelet alloimmunization and alloimmune platelet refractoriness and induction of tolerance in transfused recipients | 🖼🧊📄§ | 2026-04-14 | 2042-09-28 | 0 | 31 |
| 12600775 | Chimeric antigen receptor T cell therapy | 🖼🧊📄§ | 2026-04-14 | 2040-11-06 | 0 | 31 |
| 12600808 | Crosslinkable prepolymers for chemically stable polymer gels | 🖼🧊📄§ | 2026-04-14 | 2041-05-11 | 0 | 31 |
| 12600756 | Recombinant modified fibroblast growth factors and therapeutic uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-09-07 | 0 | 31 |
| 12599150 | Highly emulsifiable albumen hydrolysate | 🖼🧊📄§ | 2026-04-14 | 2041-06-09 | 0 | 31 |
| 12599605 | Uric acid liposomes | 🖼🧊📄§ | 2026-04-14 | 2042-10-25 | 0 | 31 |
| 12599589 | Prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome | 🖼🧊📄§ | 2026-04-14 | 2040-12-24 | 0 | 31 |
| 12599153 | Compositions and methods for reducing greenhouse gas | 🖼🧊📄§ | 2026-04-14 | 2043-03-23 | 0 | 31 |
| 12599666 | Photolytic compounds and triplet-triplet annihilation mediated photolysis | 🖼🧊📄§ | 2026-04-14 | 2040-10-07 | 0 | 31 |
| 12600986 | Nucleic acid molecules containing spacers and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2042-01-21 | 0 | 31 |
| 12599574 | Process of making membrane lipid coated nanoparticles | 🖼🧊📄§ | 2026-04-14 | 2040-07-16 | 0 | 31 |
| 12599604 | Application of JAK inhibitor in kidney disease | 🖼🧊📄§ | 2026-04-14 | 2041-12-10 | 0 | 31 |
| 12600765 | Target for anti-cancer and immune-enhancing | 🖼🧊📄§ | 2026-04-14 | 2041-04-09 | 0 | 31 |
| 12600781 | Tumor-targeted agonistic CD28 antigen binding molecules | 🖼🧊📄§ | 2026-04-14 | 2042-11-17 | 0 | 31 |
| 12600780 | Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2043-11-17 | 0 | 31 |
| 12600776 | Anti-L1CAM antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same | 🖼🧊📄§ | 2026-04-14 | 2039-10-21 | 0 | 31 |
| 12600785 | Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene | 🖼🧊📄§ | 2026-04-14 | 2041-02-15 | 0 | 31 |
| 12600784 | Anti-Clec12A antibodies and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-04-25 | 0 | 31 |
| 12600788 | Compositions and methods for treatment of thyroid eye disease | 🖼🧊📄§ | 2026-04-14 | 2045-06-18 | 0 | 31 |
| 12600792 | Monoclonal antibodies and methods of use | 🖼🧊📄§ | 2026-04-14 | 2042-03-24 | 0 | 31 |
| 12600819 | Composition for fast-cured thermosets containing amines, thiols and unsaturated molecules | 🖼🧊📄§ | 2026-04-14 | 2040-12-16 | 0 | 31 |
| 12600946 | Method for increasing dendritic cell migration ability, and use thereof | 🖼🧊📄§ | 2026-04-14 | 2039-01-28 | 0 | 31 |
| 12600949 | Modified macrophages, compositions and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2041-04-19 | 0 | 31 |